Phthisiology

Phthisiology

Blue plaque commemorating Robert W. Philip, a pioneer in phthisiology.

Phthisiology is the study of tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis. The term "phthisiology" is derived from the Greek word "phthisis," meaning "consumption," which was historically used to describe the wasting away of the body due to tuberculosis.

History

The study of tuberculosis dates back to ancient times, with evidence of the disease found in Egyptian mummies. However, it was not until the 19th century that significant advances were made in understanding and treating the disease. The discovery of the tubercle bacillus by Robert Koch in 1882 was a pivotal moment in the field of phthisiology.

Robert W. Philip

Robert W. Philip's contributions to phthisiology are commemorated in Edinburgh.

One of the key figures in the development of phthisiology was Robert W. Philip, a Scottish physician who established the first tuberculosis dispensary in Edinburgh in 1887. Philip's work laid the foundation for the modern understanding of tuberculosis as a public health issue, emphasizing the importance of early diagnosis and community-based treatment.

Pathophysiology

Tuberculosis primarily affects the lungs, but it can also impact other parts of the body, such as the kidneys, spine, and brain. The disease is transmitted through airborne droplets when an infected person coughs or sneezes. Once inhaled, the bacteria can remain dormant in the body for years before becoming active.

Diagnosis

The diagnosis of tuberculosis involves a combination of clinical evaluation, chest X-rays, and microbiological testing. The Mantoux test and interferon-gamma release assays (IGRAs) are commonly used to detect latent TB infection.

Treatment

The treatment of tuberculosis requires a prolonged course of antibiotics, typically lasting six months or more. The standard regimen includes drugs such as isoniazid, rifampicin, ethambutol, and pyrazinamide. Drug-resistant strains of tuberculosis, such as multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB), pose significant challenges to treatment.

Prevention

Preventive measures for tuberculosis include vaccination with the BCG vaccine, which provides some protection against severe forms of TB in children. Public health strategies also focus on early detection and treatment of active cases to prevent transmission.

Related pages

• Tuberculosis
• Robert Koch
• BCG vaccine
• Multidrug-resistant tuberculosis